Get started
Author

Yevgeniy Samyshkin

Observed names: Samyshkin, Y A Samyshkin, Y Samyshkin, Y. Samyshkin, Y.A. Samyshkin, Yevgeniy SAMYSHKIN, Yvevgeniy Aleksievich Samyshkin
Observed institutions: King's College London, GlaxoSmithKline (United Kingdom), IQVIA (United States), GlaxoSmithKline (United States), GlaxoSmithKline Research & Development Limited (United Kingdom), Imperial College London, London School of Economics and Political Science
ORCID: 0000-0003-3561-5585
Observed ORCID: 0000-0003-3561-5585
OpenAlex ID: A5058866426
Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit
2016 · M. Baxter, R. Hudson, et al. · Diabetic Medicine · 118
PDF
Cost-Effectiveness of Stroke Unit Care Followed by Early Supported Discharge
2008 · Ömer Saka, Victoria Serra, et al. · Stroke · 105
PDF
A framework and toolkit for capturing the communicable disease programmes within health systems: Tuberculosis control as an illustrative example
2004 · R.A. Atun, N Lennox-Chhugani, et al. · European Journal of Public Health · 75
Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery
2007 · Rachel Jenkins, Stuart Lancashire, et al. · Bulletin of the World Health Organization · 65
PDF
Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension
2019 · David G. Kiely, Orla Doyle, et al. · Pulmonary Circulation · 62
PDF
Seasonal variation and hospital utilization for tuberculosis in Russia: hospitals as social care institutions
2005 · R.A. Atun, Y.A. Samyshkin, et al. · European Journal of Public Health · 58
PDF
Barriers to sustainable tuberculosis control in the Russian Federation health system.
2005 · R A Atun, Y A Samyshkin, et al. · Europe PMC (PubMed Central) · 56
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios
2014 · Martine Hoogendoorn, Talitha L. Feenstra, et al. · Value in Health · 48
PDF
Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis
2012 · Nadine Hertel, Kotchie, et al. · International Journal of COPD · 46
PDF
Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment.
2003 · R J Coker, B Dimitrova, et al. · PubMed · 42
Health systems efficiency in the Russian Federation: tuberculosis control
2004 · Katherine Floyd, Raymond Hutubessy, et al. · Bulletin of the World Health Organization · 36
Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US
2012 · Yevgeniy Samyshkin, Anne-Laure Guillermin, et al. · Journal of Medical Economics · 35
PDF
Health system factors impacting on delivery of mental health services in Russia: Multi-methods study
2006 · David McDaid, Yvevgeniy Aleksievich Samyshkin, et al. · Health Policy · 34
Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis
2012 · Won Chan Lee, Yevgeniy Samyshkin, et al. · Journal of Medical Economics · 33
PDF
High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project
2018 · Rito Bergemann, James Allsopp, et al. · Pulmonary Circulation · 29
PDF
Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom
2013 · Yevgeniy Samyshkin, Robert W. Kotchie, et al. · The European Journal of Health Economics · 29
PDF
External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting
2017 · Martine Hoogendoorn, Talitha L. Feenstra, et al. · Value in Health · 24
Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
2013 · Yevgeniy Samyshkin, Schlunegger, et al. · International Journal of COPD · 24
PDF
Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States
2012 · Anne-Laure Guillermin, Adam Lloyd, et al. · Journal of Medical Economics · 23
PDF
Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis
2011 · Anne-Laure Guillermin, Yevgeniy Samyshkin, et al. · Journal of Medical Economics · 16
Social factors influencing hospital utilisation by tuberculosis patients in the Russian Federation: analysis of routinely collected data.
2005 · R A Atun, Y A Samyshkin, et al. · PubMed · 16
Health system frailties in tuberculosis service provision in Russia: an analysis through the lens of formal nutritional support
2005 · R.J. Coker, B. Dimitrova, et al. · Public Health · 16
Mental Health Care Reforms in Europe: Rehabilitation and Social Inclusion of People With Mental Illness in Russia
2010 · Rachel Jenkins, David McDaid, et al. · Psychiatric Services · 15
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
2016 · Martine Hoogendoorn, Talitha L. Feenstra, et al. · Value in Health · 12
PDF
Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer
2022 · Domenica Lorusso, Holly Guy, et al. · Cancers · 11
PDF
Works count: 68
Citation count: 1,086
H-index: 19
I10-index: 25
Year
Topic
Type